Cargando…
Identification of similar epitopes between severe acute respiratory syndrome coronavirus‐2 and Bacillus Calmette–Guérin: potential for cross‐reactive adaptive immunity
OBJECTIVES: Bacillus Calmette–Guérin (BCG) vaccination has been implicated in protection against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) and as a non‐specific immunisation method against the virus. We therefore decided to investigate T‐cell and B‐cell epitopes within the BCG‐Pas...
Autores principales: | Urbán, Szabolcs, Paragi, Gábor, Burián, Katalin, McLean, Gary R, Virok, Dezső P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724920/ https://www.ncbi.nlm.nih.gov/pubmed/33318797 http://dx.doi.org/10.1002/cti2.1227 |
Ejemplares similares
-
Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021) -
VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951) -
Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007) -
Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)